Patient Priorities Care Among Persons Living With Mild Cognitive Impairment and Dementia
NCT ID: NCT06001775
Last Updated: 2025-08-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
173 participants
INTERVENTIONAL
2023-08-31
2025-02-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* demonstrate the feasibility of using the electronic health record to identify a diverse cohort of eligible patient and patient-care partner dyads who will engage in a Patient Priorities Care conversation with a trained facilitator.
* demonstrate feasibility of pragmatically assessing clinical outcomes using the electronic health record, including a) number of days at home, b) total medications, and c) new referrals to specialist physicians.
* examine key feasibility measures across racial, ethnic, and socioeconomic subgroups.
Participants will receive a packet of information about Patient Priorities Care from their primary care clinic, in advance of their next upcoming clinic appointment. Individuals who receive a packet will have the opportunity to engage in a conversation about what matters most to them and what their priorities are, with trained facilitators at the clinic.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Care Management for Patients With Alzheimer Disease and Their Family Caregivers
NCT00246896
Improving How People Living With Dementia Are Selected for Care Coordination
NCT05651308
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
NCT06403345
Indiana University Dementia Screening Trial
NCT01699503
Alzheimer's Disease Multiple Intervention Trial
NCT01314950
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient Priorities Care Eligible Persons Living With Dementia and Mild Cognitive Impairment
Patients (and their care partners when available) will receive a packet of information about Patient Priorities Care, and when feasible, a trained facilitator(s) will initiate a Patient Priorities Care conversation with the patient or patient care partner dyad. This conversation will be documented in the Electronic Health Record.
Patient Priorities Care
According to patientprioritiescare.org a Patient Priorities Care conversation helps to align healthcare decision-making and care by all clinicians with patients' own health priorities. Patient Priorities Care involves not only the health outcome goals that patients want to achieve, but also their preferences for healthcare.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Patient Priorities Care
According to patientprioritiescare.org a Patient Priorities Care conversation helps to align healthcare decision-making and care by all clinicians with patients' own health priorities. Patient Priorities Care involves not only the health outcome goals that patients want to achieve, but also their preferences for healthcare.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 40 years or older
* English-speaking at both Indiana sites or English and/or Spanish speaking at the University of Texas site
* Receiving care with a participating physician
* Has a scheduled outpatient care visit within 1-2 months (60 days)
* Individual has a diagnosis of MCI or dementia
Definition: To identify individuals with dementia and MCI, we will use two or more instances of use of an ICD-10 code for either diagnosis in the EHR within 24 months. Typically, we would include instances of these billing codes within a year of each other but, due to the COVID-19 pandemic, recognize that there may be less frequent clinical visits and less robust billing. Diagnostic codes include:
• F01.50, F01.51, F02.80, F02.81, F03.90, G30.0, G30.1, G30.8, G30.9, G31.01, G31.09, G31.1, G31.2, F41.81, G31.84 and F03.91.
Care partners must meet all of the following criteria to participate in the study:
* 18 years or older
* English-speaking at both Indiana sites or English and/or Spanish speaking at the University of Texas site
A note about inclusion of care partners: Clinician determination of a patient's capacity to participate in a visit independently is part of a pragmatic approach. This means that clinic staff will determine when a care partner is needed. Generally, we act under the assumption that patients who require a care partner will have already included them in previous visits and/or provider communications (and we anticipate that this will be documented in the EHR), whereas patients who attend clinic visits independently and have no documentation indicating the involvement of a care partner in their medical decisions, or a need for one, will be determined to have the capacity to also participate in a PPC visit.
Exclusion Criteria
* Is not community-dwelling- e.g. lives in a nursing home
* Is enrolled in hospice
* Individuals who decline to receive the PPC intervention (i.e. decline to have the PPC conversation) will be excluded from the study.
* Note that declining to receive the PPC intervention will in no way impact the care that patients receive now or in the future.
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health (NIH)
NIH
National Institute on Aging (NIA)
NIH
Indiana University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jennifer L Carnahan
Research Scientist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer L Carnahan, MD
Role: PRINCIPAL_INVESTIGATOR
Regenstrief Institute, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eskenazi Health
Indianapolis, Indiana, United States
Indiana University Health Connected Care
Indianapolis, Indiana, United States
University of Texas Health- Houston
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Patient Priorities Care homepage
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15345
Identifier Type: OTHER
Identifier Source: secondary_id
Pro00063400
Identifier Type: OTHER
Identifier Source: secondary_id
FY22_Pilot1_Carnahan
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.